Advisor Group Holdings, Inc. F Star Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$4.09 - $6.86 $7,366 - $12,354	-1,801 Reduced 42.63%	2,424 $15,000
Q3 2022 Nov 14, 2022	SELL	$5.41 - $6.74 $3,900 - $4,859	-721 Reduced 14.58%	4,225 $22,000
Q2 2022 Aug 10, 2022	BUY	$2.18 - $6.39 $1,349 - $3,955	619 Added 14.31%	4,946 $31,000
Q1 2022 May 04, 2022	BUY	$2.77 - $5.36 $9,138 - $17,682	3,299 Added 320.91%	4,327 $15,000
Q3 2021 Nov 05, 2021	BUY	$5.2 - $8.42 $1,508 - $2,441	290 Added 39.3%	1,028 $8,000
Q2 2021 Aug 02, 2021	BUY	$6.57 - $10.71 $2,108 - $3,437	321 Added 76.98%	738 $6,000
Q1 2021 May 13, 2021	BUY	$7.09 - $13.84 $1,155 - $2,255	163 Added 64.17%	417 $5,000
Q4 2020 Feb 10, 2021	BUY	$1.03 - $10.39 $261 - $2,639	254 New	254 $3,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.